Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CNXU
CNXU
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CNXU News
Conexeu Completes 12-Month P.R.O.O.F Study Supporting Market Entry
4h ago
NASDAQ.COM
Conexeu Completes CXU Preclinical Phase, Targeting Medical Aesthetics Market
22h ago
Newsfilter
Conexeu Completes CXU Preclinical Program for Medical Aesthetics Market Entry
23h ago
PRnewswire
Conexeu Sciences Targets GLP-1 Aesthetics Market with Innovative Platform
Jun 25 2026
Newsfilter
Conexeu Opens New R&D Facility in Vancouver to Advance Tissue Regeneration
Jun 25 2026
Newsfilter
Regenerative Medicine Market Rapid Expansion
Jun 18 2026
Newsfilter
Rapid Expansion of the Regenerative Medicine Market
Jun 18 2026
Globenewswire
CervoMed and Others See Significant Stock Gains
Jun 17 2026
NASDAQ.COM
Conexeu Sciences Advances Wound Care Technology
Jun 16 2026
Globenewswire
Conexeu Sciences Advances Wound Care Technology with Regulatory Progress
Jun 16 2026
Newsfilter
Conexeu Sciences Expands Board to Support Commercialization Efforts
Jun 16 2026
PRnewswire
Conexeu Sciences Appoints New Executives to Drive Growth
Jun 15 2026
Newsfilter
Conexeu Advances CXU™ Wound Care Device Manufacturing
Jun 08 2026
Newsfilter
Conexeu Sciences to Ring Nasdaq Closing Bell Celebrating Public Listing
Jun 03 2026
Newsfilter
Turn Therapeutics Stock Rises 20% on Positive Trial Results
Jun 02 2026
NASDAQ.COM
Conexeu Launches Preclinical Program for B.R.E.A.S.T.™ Bioregenerative Matrix
May 27 2026
Newsfilter
Show More News
